Antti Jekunen

2.2k total citations
102 papers, 1.5k citations indexed

About

Antti Jekunen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Antti Jekunen has authored 102 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 37 papers in Molecular Biology. Recurrent topics in Antti Jekunen's work include Lung Cancer Treatments and Mutations (17 papers), Cancer Treatment and Pharmacology (13 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). Antti Jekunen is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Cancer Treatment and Pharmacology (13 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). Antti Jekunen collaborates with scholars based in Finland, Sweden and United States. Antti Jekunen's co-authors include Kalevi Kairemo, Seppo Pyrhönen, Tatyana Vlaykova, Heidi Andersén, Stephen B. Howell, K. Mattson, Natalja Eigėlienė, Jatta Saarenheimo, Kari Alitalo and Hans Ramsay and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Antti Jekunen

97 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antti Jekunen Finland 23 610 594 399 263 186 102 1.5k
Emily Dunn United States 13 873 1.4× 741 1.2× 492 1.2× 220 0.8× 132 0.7× 24 1.7k
Raffaele Longo Italy 19 571 0.9× 567 1.0× 297 0.7× 326 1.2× 142 0.8× 64 1.5k
Aristidis Polyzos Greece 24 1.3k 2.1× 718 1.2× 481 1.2× 366 1.4× 275 1.5× 67 2.4k
Haruhiko Makino Japan 20 673 1.1× 431 0.7× 345 0.9× 129 0.5× 142 0.8× 83 1.6k
Eijiro Nakamura Japan 19 574 0.9× 512 0.9× 472 1.2× 241 0.9× 233 1.3× 59 1.4k
David R. Gandara United States 24 834 1.4× 573 1.0× 507 1.3× 198 0.8× 405 2.2× 47 1.6k
Laura Zanotti Italy 27 527 0.9× 546 0.9× 341 0.9× 352 1.3× 214 1.2× 76 1.9k
Cheol Hyeon Kim South Korea 21 828 1.4× 643 1.1× 950 2.4× 271 1.0× 107 0.6× 66 1.7k
David Nathanson United States 24 901 1.5× 608 1.0× 213 0.5× 411 1.6× 369 2.0× 76 2.1k

Countries citing papers authored by Antti Jekunen

Since Specialization
Citations

This map shows the geographic impact of Antti Jekunen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antti Jekunen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antti Jekunen more than expected).

Fields of papers citing papers by Antti Jekunen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antti Jekunen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antti Jekunen. The network helps show where Antti Jekunen may publish in the future.

Co-authorship network of co-authors of Antti Jekunen

This figure shows the co-authorship network connecting the top 25 collaborators of Antti Jekunen. A scholar is included among the top collaborators of Antti Jekunen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antti Jekunen. Antti Jekunen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jekunen, Antti, et al.. (2025). Association of health literacy with cancer survival: a single-centre prospective cohort study. Acta Oncologica. 64. 499–506.
2.
Mali, Pekka, Anu Anttonen, Kaisa Lehtiö, et al.. (2025). Changes in the use of chemoradiotherapy for non-small cell lung cancer after guideline implementation in Finland between 2016 and 2020. Cancer Treatment and Research Communications. 45. 100996–100996. 1 indexed citations
3.
4.
5.
Johansson, Mikael, et al.. (2023). Socioeconomic status and lifestyle patterns in the most common cancer types-community-based research. BMC Public Health. 23(1). 1722–1722. 15 indexed citations
6.
Jekunen, Antti, et al.. (2022). Impact of sex and age on adherence to guidelines in non-small cell lung cancer management. Cancer Treatment and Research Communications. 34. 100675–100675. 6 indexed citations
7.
Saarenheimo, Jatta, Heidi Andersén, Natalja Eigėlienė, & Antti Jekunen. (2021). Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer – A Systematic Review. Frontiers in Oncology. 11. 754427–754427. 6 indexed citations
8.
Saarenheimo, Jatta, Natalja Eigėlienė, Gajja S. Salomons, et al.. (2021). Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population. Cancer Chemotherapy and Pharmacology. 87(5). 657–663. 12 indexed citations
9.
Saarenheimo, Jatta, Natalja Eigėlienė, Heidi Andersén, Marja Tiirola, & Antti Jekunen. (2019). The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer. Frontiers in Oncology. 9. 129–129. 62 indexed citations
10.
Pelttari, Liisa M., Paula Poikonen‐Saksela, Antti Jekunen, et al.. (2017). CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population. BMC Cancer. 17(1). 620–620. 28 indexed citations
11.
Ollikainen, Tiina, Aija Knuuttila, Satu Suhonen, et al.. (2000). In vitro sensitivity of normal human mesothelial and malignant mesothelioma cell lines to four new chemotherapeutic agents. Anti-Cancer Drugs. 11(2). 93–99. 22 indexed citations
12.
Minn, Heikki, et al.. (1999). 178 Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: A prospective randomized study. International Journal of Radiation Oncology*Biology*Physics. 45(3). 239–239. 5 indexed citations
13.
Vlaykova, Tatyana, et al.. (1997). Increased Thymidylate Synthase Gene Expression in Metastatic Melanoma. Oncology. 54(2). 146–152. 7 indexed citations
14.
Jekunen, Antti & Kalevi Kairemo. (1997). Inhibition of malignant angiogenesis. Cancer Treatment Reviews. 23(4). 263–286. 17 indexed citations
15.
16.
Kairemo, Kalevi, et al.. (1996). Modulation of antibody kinetics by the cell membrane active agent tween 80 in vivo.. PubMed. 16(6B). 3542–50. 3 indexed citations
17.
Kairemo, Kalevi, et al.. (1996). Double-Tracer Dosimetry of Organs in Assessment of Bone Marrow Involvement by Two Monoclonal Antibodies. Acta Oncologica. 35(3). 357–365. 2 indexed citations
18.
Saarinen, Antti, et al.. (1996). A phase II trial of docetaxel in advanced nonsmall cell lung cancer. Anti-Cancer Drugs. 7(8). 890–892. 15 indexed citations
19.
Jekunen, Antti, et al.. (1993). Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochemical Pharmacology. 45(10). 2079–2085. 31 indexed citations
20.
Jekunen, Antti, et al.. (1983). Exclusion of exogenous 5-methyl-2'-deoxycytidine from DNA in human leukemic cells. Biochemical Pharmacology. 32(7). 1165–1168. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily Dunn Breakdown of academic impact, for papers by Raffaele Longo Breakdown of academic impact, for papers by Aristidis Polyzos Breakdown of academic impact, for papers by Haruhiko Makino Breakdown of academic impact, for papers by Eijiro Nakamura Breakdown of academic impact, for papers by David R. Gandara Breakdown of academic impact, for papers by Laura Zanotti Breakdown of academic impact, for papers by Cheol Hyeon Kim Breakdown of academic impact, for papers by David Nathanson
Rankless by CCL
2026